PRELUDE CAPITAL MANAGEMENT, LLC - HORIZON PHARMA PLC ownership

HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 288 filers reported holding HORIZON PHARMA PLC in Q1 2019. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of HORIZON PHARMA PLC
ValueSharesWeighting
Q1 2019$7,000
-68.2%
275
-83.8%
0.00%
-100.0%
Q3 2017$22,000
-96.3%
1,700
-95.8%
0.00%
-96.5%
Q1 2017$591,000
-9.4%
40,000
-0.7%
0.06%
-27.8%
Q4 2016$652,000
+96.4%
40,300
+120.2%
0.08%
+125.7%
Q3 2016$332,000
+41.9%
18,300
+69.4%
0.04%
-2.8%
Q4 2015$234,000
+27.2%
10,800
+103.8%
0.04%
+38.5%
Q2 2015$184,0005,3000.03%
Other shareholders
HORIZON PHARMA PLC shareholders Q1 2019
NameSharesValueWeighting ↓
JABODON PT CO 187,808$4,519,0003.52%
KNOTT DAVID M 50,046$1,204,0000.51%
CASTLEARK MANAGEMENT LLC 362,980$8,733,0000.34%
EAGLE ASSET MANAGEMENT INC 2,692,100$64,771,0000.33%
USA FINANCIAL FORMULAS 15,202$402,0000.20%
Qtron Investments LLC 12,274$295,0000.18%
C WorldWide Group Holding A/S 491,544$11,827,0000.15%
Gotham Asset Management, LLC 207,158$4,984,0000.08%
Russell Investments Group, Ltd. 608,977$14,652,0000.03%
FNY Investment Advisers, LLC 3,350$80,0000.02%
View complete list of HORIZON PHARMA PLC shareholders